Related Experiment Video
Updated: Apr 7, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Glycoconjugate Vaccines: The Regulatory Framework
1Laboratory for Molecular Structure, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK, chrisjones715@btinternet.com.
Insights
Ensuring the safety of carbohydrate-based vaccines is crucial for regulatory approval and public trust. Rigorous analytical methods are essential for consistent quality control in vaccine manufacturing.
Area of Science:
- Vaccinology
- Analytical Chemistry
- Regulatory Science
Background:
- Vaccines, particularly glycoconjugate vaccines, are vital for preventing infant diseases.
- Vaccine safety is paramount, influencing individual health and public confidence.
- Stringent regulatory standards govern vaccine development and approval.
Purpose of the Study:
- To review regulatory considerations for carbohydrate-based vaccines.
- To emphasize analytical techniques for ensuring vaccine quality.
Main Methods:
- Focus on regulatory requirements for vaccine safety.
- Discussion of analytical approaches for quality control.
- Examination of methods ensuring lot-to-lot consistency.
Main Results:
- Regulatory scrutiny for vaccines, especially those for infants, is exceptionally high.
- Analytical methods are key to verifying the safety and efficacy of carbohydrate-based vaccines.
- Consistent manufacturing quality is a critical regulatory demand.
Conclusions:
- Adherence to rigorous safety standards is non-negotiable for vaccine approval.
- Advanced analytical strategies are indispensable for guaranteeing the quality of carbohydrate-based vaccines.
- Maintaining consistent manufacturing quality builds essential public trust in vaccination programs.
Abstract:
Most vaccines, including the currently available glycoconjugate vaccines, are administered to healthy infants, to prevent future disease. The safety of a prospective vaccine is a key prerequisite for approval. Undesired side effects would not only have the potential to damage the individual infant but also lead to a loss of confidence in the respective vaccine-or vaccines in general-on a population level. Thus, regulatory requirements, particularly with regard to safety, are extremely rigorous. This chapter highlights regulatory aspects on carbohydrate-based vaccines with an emphasis on analytical approaches to ensure the consistent quality of successive manufacturing lots.
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Conjugated Proteins
Vaccine Production
Global Regulatory Systems
Vaccines
Drug Products: Biologics, Biosimilars and Interchangeables

